These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

715 related items for PubMed ID: 27538418

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Clinical and demographic correlates of apathy in Parkinson's disease.
    Brown DS, Barrett MJ, Flanigan JL, Sperling SA.
    J Neurol; 2019 Feb; 266(2):507-514. PubMed ID: 30604055
    [Abstract] [Full Text] [Related]

  • 49. Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.
    Müller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Bohnen NI.
    Brain; 2013 Nov; 136(Pt 11):3282-9. PubMed ID: 24056537
    [Abstract] [Full Text] [Related]

  • 50. Emotional manifestations of PD: Neurobiological basis.
    Castrioto A, Thobois S, Carnicella S, Maillet A, Krack P.
    Mov Disord; 2016 Aug; 31(8):1103-13. PubMed ID: 27041545
    [Abstract] [Full Text] [Related]

  • 51. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
    Qamhawi Z, Towey D, Shah B, Pagano G, Seibyl J, Marek K, Borghammer P, Brooks DJ, Pavese N.
    Brain; 2015 Oct; 138(Pt 10):2964-73. PubMed ID: 26209314
    [Abstract] [Full Text] [Related]

  • 52. Molecular Imaging of the Serotonergic System in Parkinson's Disease.
    Pagano G, Politis M.
    Int Rev Neurobiol; 2018 Oct; 141():173-210. PubMed ID: 30314596
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter.
    Strecker K, Wegner F, Hesse S, Becker GA, Patt M, Meyer PM, Lobsien D, Schwarz J, Sabri O.
    J Neurol; 2011 Jan; 258(1):19-26. PubMed ID: 20644949
    [Abstract] [Full Text] [Related]

  • 56. Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson's disease with depression.
    Wei L, Hu X, Yuan Y, Liu W, Chen H.
    Behav Brain Res; 2018 Jul 16; 347():132-139. PubMed ID: 29530489
    [Abstract] [Full Text] [Related]

  • 57. Postoperative apathy can neutralise benefits in quality of life after subthalamic stimulation for Parkinson's disease.
    Martinez-Fernandez R, Pelissier P, Quesada JL, Klinger H, Lhommée E, Schmitt E, Fraix V, Chabardes S, Mertens P, Castrioto A, Kistner A, Broussolle E, Pollak P, Thobois S, Krack P.
    J Neurol Neurosurg Psychiatry; 2016 Mar 16; 87(3):311-8. PubMed ID: 25934016
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
    Le Heron C, Plant O, Manohar S, Ang YS, Jackson M, Lennox G, Hu MT, Husain M.
    Brain; 2018 May 01; 141(5):1455-1469. PubMed ID: 29672668
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 36.